A novel UPLC – PDA method for simultaneous determination of hydroquinone, oxybenzone and octinoxate: An in-vitro study

Melasma, a type of hyperpigmentation, is a difficult condition to treat. Several topical therapies have been proposed to meet the therapeutic goals of this condition, one of which is the combination of hydroquinone, oxybenzone, and octinoxate. The current study aims to develop a robust and reliable...

Full description

Saved in:
Bibliographic Details
Main Authors: Ram Kumar Gummaluri, Ramakrishna Karipeddi
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Kuwait Journal of Science
Subjects:
Online Access:https://www.sciencedirect.com/science/article/pii/S2307410823000780
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849699405843660800
author Ram Kumar Gummaluri
Ramakrishna Karipeddi
author_facet Ram Kumar Gummaluri
Ramakrishna Karipeddi
author_sort Ram Kumar Gummaluri
collection DOAJ
description Melasma, a type of hyperpigmentation, is a difficult condition to treat. Several topical therapies have been proposed to meet the therapeutic goals of this condition, one of which is the combination of hydroquinone, oxybenzone, and octinoxate. The current study aims to develop a robust and reliable analytical method for determining hydroquinone, oxybenzone, and octinoxate in fixed dosage forms simultaneously. In pharmacopoeias, the scope for simultaneous drug determinations is always limited, so the current work is an attempt to develop a method for routine analysis of this combination in quality control. On Water's Acquity system with an X-Bridge C8 column (100 ​mm 3.0 ​mm, 3.5 ​μm), an isocratic mobile phase of 30:70 v/v acetonitrile and buffer were used to achieve chromatographic separation. The flow rate is 0.5 ​ml per minute, and the detection wavelength is 230 ​nm. By subjecting the APIs to various stressors, the method's ability to indicate stability was demonstrated. The method validation followed ICH guidelines. The results of the research for system acceptability, reproducibility, detection limits, quantitation limits, linearity, accuracy, precision, and specificity are all within acceptable bounds. The reliability and analytical performance of the proposed method for its linearity ranges, system suitability, accuracy, precision, robustness detection, and quantification limits were statistically validated and found to be in consistent with ICH Q2 (R1) recommendations.
format Article
id doaj-art-299fe0f56aff4ddf987715b59b887f29
institution DOAJ
issn 2307-4116
language English
publishDate 2023-07-01
publisher Elsevier
record_format Article
series Kuwait Journal of Science
spelling doaj-art-299fe0f56aff4ddf987715b59b887f292025-08-20T03:18:35ZengElsevierKuwait Journal of Science2307-41162023-07-01503282289https://doi.org/10.1016/j.kjs.2023.02.026A novel UPLC – PDA method for simultaneous determination of hydroquinone, oxybenzone and octinoxate: An in-vitro studyRam Kumar Gummaluri0Ramakrishna Karipeddi1Dept. of Chemistry, MVGR College of Engineering, IndiaDept. of Chemistry, GIS, GITAM (Deemed to be University), IndiaMelasma, a type of hyperpigmentation, is a difficult condition to treat. Several topical therapies have been proposed to meet the therapeutic goals of this condition, one of which is the combination of hydroquinone, oxybenzone, and octinoxate. The current study aims to develop a robust and reliable analytical method for determining hydroquinone, oxybenzone, and octinoxate in fixed dosage forms simultaneously. In pharmacopoeias, the scope for simultaneous drug determinations is always limited, so the current work is an attempt to develop a method for routine analysis of this combination in quality control. On Water's Acquity system with an X-Bridge C8 column (100 ​mm 3.0 ​mm, 3.5 ​μm), an isocratic mobile phase of 30:70 v/v acetonitrile and buffer were used to achieve chromatographic separation. The flow rate is 0.5 ​ml per minute, and the detection wavelength is 230 ​nm. By subjecting the APIs to various stressors, the method's ability to indicate stability was demonstrated. The method validation followed ICH guidelines. The results of the research for system acceptability, reproducibility, detection limits, quantitation limits, linearity, accuracy, precision, and specificity are all within acceptable bounds. The reliability and analytical performance of the proposed method for its linearity ranges, system suitability, accuracy, precision, robustness detection, and quantification limits were statistically validated and found to be in consistent with ICH Q2 (R1) recommendations.https://www.sciencedirect.com/science/article/pii/S2307410823000780melasmahyperpigmentationuplc-pda methodhydroquinoneoxybenzone
spellingShingle Ram Kumar Gummaluri
Ramakrishna Karipeddi
A novel UPLC – PDA method for simultaneous determination of hydroquinone, oxybenzone and octinoxate: An in-vitro study
Kuwait Journal of Science
melasma
hyperpigmentation
uplc-pda method
hydroquinone
oxybenzone
title A novel UPLC – PDA method for simultaneous determination of hydroquinone, oxybenzone and octinoxate: An in-vitro study
title_full A novel UPLC – PDA method for simultaneous determination of hydroquinone, oxybenzone and octinoxate: An in-vitro study
title_fullStr A novel UPLC – PDA method for simultaneous determination of hydroquinone, oxybenzone and octinoxate: An in-vitro study
title_full_unstemmed A novel UPLC – PDA method for simultaneous determination of hydroquinone, oxybenzone and octinoxate: An in-vitro study
title_short A novel UPLC – PDA method for simultaneous determination of hydroquinone, oxybenzone and octinoxate: An in-vitro study
title_sort novel uplc pda method for simultaneous determination of hydroquinone oxybenzone and octinoxate an in vitro study
topic melasma
hyperpigmentation
uplc-pda method
hydroquinone
oxybenzone
url https://www.sciencedirect.com/science/article/pii/S2307410823000780
work_keys_str_mv AT ramkumargummaluri anoveluplcpdamethodforsimultaneousdeterminationofhydroquinoneoxybenzoneandoctinoxateaninvitrostudy
AT ramakrishnakaripeddi anoveluplcpdamethodforsimultaneousdeterminationofhydroquinoneoxybenzoneandoctinoxateaninvitrostudy
AT ramkumargummaluri noveluplcpdamethodforsimultaneousdeterminationofhydroquinoneoxybenzoneandoctinoxateaninvitrostudy
AT ramakrishnakaripeddi noveluplcpdamethodforsimultaneousdeterminationofhydroquinoneoxybenzoneandoctinoxateaninvitrostudy